Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.
Galloway, S.A.E., Dolton, G., Attaf, M., Wall, A., Fuller, A., Rius, C., Bianchi, V., Theaker, S., Lloyd, A., Caillaud, M.E., Svane, I.M., Donia, M., Cole, D.K., Szomolay, B., Rizkallah, P., Sewell, A.K.(2019) Front Immunol 10: 319-319
- PubMed: 30930889 
- DOI: 10.3389/fimmu.2019.00319
- Primary Citation of Related Structures:  
6G3K, 6G3J - PubMed Abstract: 
Recent immunotherapeutic approaches using adoptive cell therapy, or checkpoint blockade, have demonstrated the powerful anti-cancer potential of CD8 cytotoxic T-lymphocytes (CTL). While these approaches have shown great promise, they are only effective i ...